RUNX1 and colorectal carcinoma: The experimental findings validate RUNX1's direct role in modulating MUC13 expression, emphasizing the critical importance of the binding site's sequence integrity for transcriptional activation and delineating the specificity of the RUNX1-MUC13 interaction as a pivotal modulator in CRC pathology.